Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Tirzepatide, also known by its brand name Mounjaro, is a medication originally approved by the to manage blood sugar levels in individuals with type 2 diabetes
This guidance advised that companies should show that the risk of cardiovascular events in T2DM patients didnt increase with the use of their new antidiabetic therapies (drugs or therapeutic biologics), a proactive response to concerns about the cardiovascular safety of some diabetes medications developed previously ( accessed August 25, 2025)
10.1001/jama.291.13.1603 300 ThankiK.BlumK.ThakurA.RoseF.FogedC
10.3 Pancreatitis & retinopathy risk Reports of pancreatitis and gastrointestinal intolerance, though infrequent, remain notable in real-world settings
US$ 27.48
US$ 21.09
)
US$ 28.52
US$ 22.80
US$ 22.44
